Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126460) titled 'Study on the Optimal Aspiration and Infusion Cycle Method for Blood Sampling via PICC in Patients with Hematological Malignancies' on June 9.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Zhenjiang First People's Hospital (Affiliated People's Hospital of Jiangsu University)
Condition:
Hematological diseases (including leukemia, lymphoma, anemia, and coagulation disorders) require long-term chemotherapy and frequent blood sampling. As the primary vascular access, PICC currently lacks standardized blood sampling protocols based on internal volume, and repeated push-pull...